Therefore, in the present study, the prognostic significance of chromatin CKAP2 was evaluated in 375 early-stage breast cancer cases, from two independent institutions, as based on the CPCC in CKAP2 immunohistochemistry. The gene discussed is CKAP2; the disease is breast cancer.